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Abstract
Background: The presence of various EPIYA tyrosine phosphorylation motifs in the CagA protein of Helicobacter
pylori has been suggested to contribute to pathogenesis in adults. In this study, a unique PCR assay and
sequencing strategy was developed to establish the number and variation of cagA EPIYA motifs.
Findings: MDA-DNA derived from gastric biopsy specimens from eleven subjects with gastritis was used with
M13- and T7-sequence-tagged primers for amplification of the cagA EPIYA motif region. Automated capillary
electrophoresis using a high resolution kit and amplicon sequencing confirmed variations in the cagA EPIYA motif
region. In nine cases, sequencing revealed the presence of AB, ABC, or ABCC (Western type) cagA EPIYA motif,
respectively. In two cases, double cagA EPIYA motifs were detected (ABC/ABCC or ABC/AB), indicating the presence
of two H. pylori strains in the same biopsy.
Conclusion: Automated capillary electrophoresis and Amplicon sequencing using a single, M13- and T7-sequence-
tagged primer pair in PCR amplification enabled a rapid molecular typing of cagA EPIYA motifs. Moreover, the
techniques described allowed for a rapid detection of mixed H. pylori strains present in the same biopsy specimen.
Background
Helicobacter pylori is a microaerophilic Gram-negative
bacterium that chronically infects the gastric mucosa. It
is recognised as a human pathogen associated not only
with chronic gastritis [1], but also with peptic ulcer [2]
and gastric cancer [3]. A commonly used molecular
marker of H. pylori virulence is the cagA gene (cyto-
toxin-associated gene) [4], which is a part of the 40 kb
Cag-Pathogenicity Island (cag-PAI) [5]. The CagA cyto-
toxin is directly injected into epithelial cells by a type IV
secretion system, encoded by genes located in the cag-
PAI [6-8]. In the host cell, CagA localises to the plasma
membrane and undergoes phosphorylation on specific
tyrosine residues within repeating penta amino acid
Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs, present at the C-
terminus of the protein [9,10]. The C-terminal part,
which contains the EPIYA motifs, has been shown to be
highly variable, as opposed to the highly conserved N-
terminal part [7,11-13]. CagA EPIYA motifs are defined
as EPIYA-A, -B, -C, and -D, according to the amino
acid sequences that surround the EPIYA sequence
[10,13,14]. CagA proteins nearly always possess EPIYA-
A and EPIYA-B sites, followed by one to three repeats
of EPIYA-C in Western-type [13] or EPIYA-D sites in
East Asian-type of H. pylori clinical isolates [14]. It has
been suggested that the variation in number of repeating
EPIYA-C or -D motifs determines the biological activity
of CagA in phosphorylation-dependent as well as phos-
phorylation-independent ways [10,15]. It has also been
shown that the number of CagA EPIYA-C motifs is an
important factor for cancer risk among Western strains
[16].
Numerous PCR assays have been reported for the
identification of CagA EPIYA phosphorylation motifs
[12-14,17,18]. To simplify the determination of the
number and types of cagA EPIYA motifs present, Argent
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and co-workers [17] developed an elegant PCR-based
approach for identification of individual EPIYA motifs,
using a single forward primer and multiple reverse pri-
mers. In most studies, cagA EPIYA amplicons have been
visualised by agarose gel electrophoresis and sequenced
using various region specific primers [12-14,17,18].
In this study, we report on the analysis of amplicons
derived from a single primer pair by automated capillary
electrophoresis combined with direct sequencing using
universal sequencing primers to assess variations in the
H. pylori cagA EPIYA motifs. The technique also works
in the presence of multiple H. pylori strains in the same
biopsy specimen.
Methods
Study subjects and tissue collection
Eleven individual archival frozen H. pylori positive gas-
tritis tissue samples were used in this study. Preparation
of multiple displacement amplified DNA (MDA-DNA)
derived from DNA isolations and the detection limit of
Helicobacter pylori MDA-DNA have been described pre-
viously [19,20].
PCR amplification
The CagA gene EPIYA repeat regions were amplified
using 10 pmol of each primer M13-CagA-EPIYA.SE (5’-
TGT AAA ACG ACG GCC AGT CCC TAG TCG GTA
ATG GRT TRT CT-3’) and T7-CagA-EPIYA.AS (5’-
TAA TAC GAC TCA CTA TAG GGT GTG GCT GTT
AGT AGC GTA ATT GTC-3’), 2 μl of MDA-DNA, and
1× HotStarTaq Master mix (Qiagen, Hilden, Germany)
in a final reaction volume of 25 μl. Amplification condi-
tions were as follows: initial denaturation at 95°C for 15
min; 30 cycles of 95°C for 30 s; 55°C for 30 s; 72°C for 1
min; and final extension at 72°C for 10 min. Prior to
sequencing, amplicons were analysed by automated
capillary electrophoresis using a QIAxcel system and a
QIAxcel DNA High Resolution kit (Qiagen, Hilden,
Germany), showing amplicons of different sizes depend-
ing on the variation and number of repeats (Figure 1).
Primers for CagE were designed from H. pylori strain
26695 [GenBank:AE000511] (CagE-M13-sense primer
5’-TGT AAA ACG ACG GCC AGT GGG GGA ATA
GGT TGT TTG GT-3’ and CagE-antisense primer 5’-
GGA TCA CCC CAT CAT CTA AAA A-3’, yielding an
amplicon of ~385 bp), whereas cag-PAI empty-site pri-
mers were from Akopyants and co-workers [6] (M13-
sense 5’-TGT AAA ACG ACG GCC AGT ACA TTT
TGG CTA AAT AAA CRC TG-3’ and cag-PAI empty-
site T7-antisense 5’-TAA TAC GAC TCA CTA TAG
GGT CAT GCG AGC GGC GAT GTG-3’, yielding an
amplicon of ~380 bp if the cag-PAI is lost. PCR amplifi-
cations were carried out as described above using the
following amplification conditions: initial denaturation
at 95°C for 15 min; 30 cycles of 95°C for 20 s; 55°C
(cagE) or 50°C (cag-PAI empty-site) for 20 s; 72°C for
40 s; and final extension at 72°C for 10 min. Subse-
quently, amplicons were analysed by automated capillary
electrophoresis as described above.
DNA sequence analysis
Amplicon sequencing was done with the specified uni-
versal primers, via a custom sequencing service (Euro-
fins MWG Operon, Ebersberg, Germany). The obtained
DNA sequences corresponding to cagA EPIYA motif
repeats, derived from the nine cagA positive isolates and
three reference strains (H. pylori 26695, J99, ATCC
43509T) were translated into amino acid sequences,
aligned and compared with catalogued H. pylori 26695
[GenBank:AE000511, H. pylori J99 [GenBank:
AE001439], H. pylori P12 [GeneBank:CP001217], H.
pylori G27 [GenBank:CP001173], and H. pylori Shi470
[GeneBank:CP001072] sequences using the CLC DNA
Workbench software [21]. Sequences were retrieved
from the NCBI nucleotide database [22].
Results and discussion
We successfully amplified the variable 3’-region of the
cagA gene in nine of eleven MDA-DNA extracts from
H. pylori positive gastritis biopsy specimens using a sin-
gle PCR amplification, followed by automated capillary
electrophoresis and universal primer-tagged amplicon
sequencing. Electrophoretic analysis of the eleven cases
revealed the presence of a single band in seven cases,
multiple bands in two cases, while two cases were PCR
negative (Figure 1; table 1). The amplicons ranged in
size between ~600 and ~900 bp, indicating the presence
of varying numbers of cagA EPIYA motifs in the differ-
ent biopsies. Amplicons derived from H. pylori 26695
and H. pylori J99 revealed bands of similar sizes,
whereas H. pylori ATCC 43509T generated a larger
amplicon of ~1000 bp (Figure 1).
To assess the presence or loss of cag-PAI, cagE and
cag-PAI empty-site PCR assay was carried out. CagE
was detected in nine of eleven cases corresponding to
the results of cagA genotyping (Table 1). Amplification
of cag-PAI empty-site yielded a fragment of ~380 bp in
biopsy specimen No. 21, revealing loss of cag-PAI. Thus,
the result confirms the absence of cagA EPIYA motif
and cagE amplicon in this biopsy specimen. H. pylori
DNA derived from biopsy specimen No. 28, negative in
cagA and cagE amplification, did not yield any empty-
site amplicon of the expected size (Table 1), suggesting
the presence of a deviating cag-PAI.
To confirm the cagA EPIYA motif genotype results
obtained by fragment length analysis, we sequenced the
amplicons using universal M13- and T7-sequencing pri-
mers. In seven of the eleven cases, an AB or ABC
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(Western type) cagA EPIYA motif was present (Table 1).
In two additional cases, double cagA EPIYA motifs
(ABC+ABCC or ABC+AB) were detected. Presumably,
this indicates the presence of two individual strains in
the same biopsy specimen (Table 1). The analysis of
cagA EPIYA motifs from mixed H. pylori strain infection
was possible by a combination of capillary electrophor-
esis and sequencing. The presence of cagA EPIYA-A
and EPIYA-B motifs could be determined from the
sequencing chromatograms, but the region of the
repeating C-motifs contained double peaks caused by
amplicons of different sizes and nucleotide composi-
tions. Instead, the high resolution capillary
electrophoreses analysis enabled us to determine the
number of EPIYA-C motifs by the size of the amplicons.
DNA sequencing of reference strains revealed the pre-
sence of a cagA EPIYA-ABC motif in H. pylori 26695, a
cagA EPIYA-BC motif in H. pylori J99, and a cagA
EPIYA-ABCCC motif in H. pylori ATCC 43509T (Table
1).
In previous reports, the 3’-end of the cagA gene
encoding the EPIYA repeats were analysed by single or
multiplex PCR assays and visualisation of amplicons by
agarose gel electrophoresis. In most studies, amplicons
are sequenced using a battery of gene specific primers
(often the PCR primers). DNA sequence analysis of
Figure 1 A) Schematic drawing of the CagA EPIYA motifs detected in our clinical samples and its approximate sizes in bp (including
the M13- and T7-sequence tags. B) Size distribution of the cagA EPIYA motif amplicons derived from MDA-DNA of eleven gastritis biopsy
specimens (No. 6, 9, 12, 14, 18, 21, 22, 23, 25, 27, and 28). J99, 26695, and 43509 indicate the position of cagA EPIYA motif amplicons derived
from H. pylori J99, 26695, and ATCC 43509T DNA, respectively. A virtual size reference marker is indicated in the left margin and a reference
marker for the different EPIYA motif sizes is indicated in the right margin. C) Representative electropherograms revealing the presence of a single
(cagA EPIYA-AB; No. 6) or two different (cagA EPIYA-AB and EPIYA-ABC; No. 27) cagA EPIYA motifs, indicating the presence of either one or two
isogenic H. pylori strains in the same biopsy specimen. 15 and 3000 indicate the position of lower and upper size markers.
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cloned amplicons with universal sequence primers (such
as M13 uni -21), targeting sequences flanking cloned
inserts [14,16,17], has also been described. The present
study describes a unique PCR assay that detects all of
the cagA phosphorylation sites, including the Asian
EPIYA-D type. Tagging of the PCR primers enables
rapid sequencing for revealing individual differences in
the samples. Moreover, many laboratory workers are
also concerned about the use of ethidium-bromide
stained agarose gels, which is a health-risk factor. In
agreement with a previous study from our laboratory we
show that the use of automated capillary electrophoresis,
which is a rapid technique that also minimizes the
health risk during electrophoresis, overcomes these
obstacles [19].
Commonly, work identifying cagA genotypes as poten-
tial virulence factors has been performed on bacterial
isolates cultured from gastric biopsy specimens. How-
ever, bacterial culture methods are often time-consum-
ing. In this view, the present and a previous study have
shown that direct PCR on MDA-DNA derived from
biopsy DNA provides a reliable source for multiple
molecular analyses [19]. Using random amplified poly-
morphic DNA (RAPD) fingerprint analysis, it was found
that ~60% of the patients were infected by two or more
different H. pylori strains [23]. Using the methodological
approaches described herein, we were able to detect
multiple DNA fragments, indicating that the method
indeed is suitable for analyzing mixed H. pylori infection
in two gastric biopsy specimens (Table 1).
Due to the limited number of biopsies analysed here,
we were not able to draw any conclusions regarding a
possible correlation between the gastritis classification
and cagA genotypes. However, the primary goal of the
present study was not to perform a clinical study at
large but rather to establish a new and simple methodo-
logical approach to assess variations in H. pylori cagA
EPIYA motifs.
Altogether, the single PCR reaction with MDA-DNA
as template, in combination with the automated capil-
lary electrophoresis and direct sequencing of universal
primer-tagged amplicons, offers a rapid means of geno-
typing H. pylori DNA isolated from biopsy specimens.
Moreover, the technique described allowed for a rapid
detection of mixed H. pylori strains present in the same
biopsy specimen.
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18 P-I-na 26695 - + ABC
21 P-I-na J99 + - -
22 C-I-a J99 - + AB
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reference strain ATCC 43509T - + ABCCC
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